Indian firm takes over German biologics plant
An Indian firm has taken over the contract biologics manufacturing business of German corporation Siegfried.
An Indian firm has taken over the contract biologics manufacturing business of German corporation Siegfried.
Two new techniques have been developed that could signal the end of PCR (polymerase chain reaction) amplification for sequencing applications and dramatically increase the efficiency of sample preparation.